Verve Ventures is a European startup investment platform based in Zug, Switzerland, that focuses on providing qualified and institutional investors access to high-potential ventures. Founded in 2010, the firm has invested over EUR 130 million in more than 140 startups across various sectors, including science, technology, clean energy, and digital health. It operates a fully digital platform allowing private investors to build diversified portfolios with investments starting at EUR 10,000. Verve Ventures boasts a community of 5,000 registered investors, including family offices and pension funds, and is backed by Zürcher Kantonalbank, one of Switzerland's largest banks. The firm employs a dedicated team of investment professionals who rigorously screen thousands of startups annually to select the top 1% for investment. Beyond capital, Verve Ventures supports startups with essential resources such as hiring and client introductions, facilitating their growth and success in competitive markets.
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.
Poppins
Venture Round in 2025
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Zero Point Motion
Seed Round in 2025
Zero Point Motion specializes in the development of advanced inertial sensors that enhance precise positioning and navigation capabilities. By integrating cavity optomechanics with hybrid micro-electro-mechanical systems and photonic integrated circuit technology, the company delivers ultra-low noise performance for measuring acceleration and rotation. This innovative approach allows for high-quality motion tracking, making it suitable for various applications, including automotive systems, consumer electronics, and robotics. Through its focus on combining state-of-the-art optical properties with the mass production of existing sensor technologies, Zero Point Motion aims to provide reliable and efficient solutions for motion detection and navigation.
Lexroom.ai
Seed Round in 2025
Lexroom.ai allows lawyers to complete hours of legal research in seconds. Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters. Lexroom.ai perfectly integrates with lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities. Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
Orakl Oncology
Seed Round in 2024
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered analysis. The company utilizes a distinct collection of patient tumor avatars that integrates both biological and clinical data to enhance cancer treatment options.
Metafuels
Series A in 2024
Metafuels is focused on developing sustainable aviation fuel (SAF) technology through its innovative aerobrew™ system, which aims to make net-zero aviation a viable option. This technology utilizes renewable feedstocks, including green hydrogen and sustainably sourced carbon dioxide, such as that captured directly from the air. By employing a highly scalable process, aerobrew™ effectively addresses the challenges of scaling and costs typically associated with alternative e-fuels. Additionally, it can utilize biogenic materials, ensuring that the carbon used does not compete with food sources. With impressive carbon conversion rates and high SAF yields, aerobrew™ promises favorable production economics. As demand for sustainable aviation fuel continues to rise, Metafuels is poised to play a significant role in the decarbonization of global aviation and in helping the industry meet its net-zero targets by 2050.
tozero
Seed Round in 2024
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, focuses on developing technology for recycling lithium-ion batteries. The company aims to create a scalable machine that recovers essential materials such as lithium, nickel, cobalt, graphite, and manganese in an environmentally sustainable manner. By facilitating the recovery of these critical materials, Tozero enables industries to reintegrate fresh raw materials back into the supply chain, thereby supporting broader decarbonization efforts.
Otoqi
Series B in 2024
Otoqi specializes in developing an automotive management platform that streamlines the entire lifecycle of vehicles. The company's technology simplifies the logistics involved in moving, servicing, charging, repairing, and delivering a large number of vehicles. By facilitating instant ordering and providing real-time visibility and control during the buying process of new and used cars, Otoqi enhances operational efficiency. Additionally, it enables quick transfers of vehicles between various sites, agencies, and partners, while also offering comprehensive vehicle testing and after-sales services. This holistic approach allows mobility operators to access a full range of services tailored to their needs.
Retinai
Series B in 2024
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Nuclera
Series C in 2024
Nuclera is a biotechnology company specializing in an automated protein prototyping system aimed at enhancing drug discovery processes. Its eProtein Discovery system enables researchers to rapidly produce and test high-quality, soluble, and active proteins, significantly accelerating protein projects. By integrating technology such as cell-free protein synthesis and digital microfluidics, Nuclera provides a high-throughput platform for automated protein access. This innovative approach allows scientists to obtain reliable proteins within a short timeframe, facilitating faster progress in their research and contributing to more efficient drug development efforts.
Somagenetix
Series A in 2024
Somagenetix is a biotechnology company focused on developing innovative gene therapies for phagocyte-related illnesses, particularly targeting severe inherited immune diseases, immunodeficiency, neurodegeneration, and cancer with brain metastases. The company specializes in discovering and developing stem cells from bone marrow and utilizing lentiviral vectors to deliver therapeutic genes. This approach aims to correct the underlying genetic defects in patients by transplanting gene-corrected cells back into the body, ultimately providing a potential cure for various monogenic disorders. With a commitment to advancing the field of gene therapy, Somagenetix aims to lead in creating first-in-class treatments that address significant medical needs.
Neo Medical
Series B in 2024
Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.
Puraffinity
Series A in 2024
Puraffinity Ltd, founded in 2015 and based in London, specializes in innovative water treatment and purification solutions. The company, which was previously known as Customem Ltd before rebranding in July 2019, has developed a sustainable bio-based adsorbent material designed to effectively remove challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry, Puraffinity's technology allows for the selective capture of micro-pollutants, including pesticides, pharmaceuticals, and hazardous chemicals such as per- and polyfluoroalkyl substances. This capability enables clients to comply with stringent wastewater regulations while contributing to the protection of local ecosystems. Puraffinity is committed to addressing pressing water quality challenges through environmentally sustainable practices.
IRUBIS
Seed Round in 2024
IRUBIS GmbH, founded in 2017 and based in Munich, Germany, specializes in the development of mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company focuses on enhancing Fourier transform infrared (FTIR) spectroscopy to improve the analysis of protein-based drugs. Its innovative measurement systems enable real-time bioreactor monitoring, allowing for the online assessment of glucose and lactate levels without contamination risks. IRUBIS also produces a range of ATR crystals, including single-reflection and signal-enhanced varieties, aimed at advancing industry standards for bioprocess monitoring. The company’s technology supports both upstream and downstream bioprocessing, facilitating metabolite monitoring and the detection of target proteins and contaminants through machine-learning evaluation software.
Cubbit
Seed Round in 2024
Cubbit is a geo-distributed cloud enabler that transforms underutilized resources at the edge of the internet into B2B cloud services. Its software can operate on existing resources, in the cloud, or at the edge, allowing for the creation of a seamless data domain. This innovative platform offers highly resilient cloud object storage while maintaining client sovereignty over data. Cubbit enables businesses to reduce storage costs by up to 80% and minimize their cloud carbon footprint, catering to traditional use cases like backup and addressing modern demands related to Edge computing, Multi-cloud environments, and Data Sovereignty. With Cubbit, companies regain full control over their data, infrastructure, and costs, all with a simple setup process that requires no upfront investment.
Axelera AI
Series B in 2024
Axelera AI focuses on providing specialized hardware and software platforms to enhance artificial intelligence tasks, particularly in edge computing. Its primary product, the Metis™ AI Platform, combines hardware and software to offer high-performance, energy-efficient AI inference solutions. The platform's innovative design has earned recognition as a CES® 2024 Innovation Awards Honoree. Established in 2021 after incubation by Bitfury and collaboration with imec, Axelera AI is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices in Belgium, Switzerland, and Italy. The company's team comprises experts in AI from leading firms and Fortune 500 companies, focusing on delivering sustainable edge applications through a custom dataflow architecture and multicore in-memory computing that minimizes power consumption.
Neustark
Venture Round in 2024
Neustark focuses on creating zero-emissions concrete by capturing carbon dioxide emissions from the atmosphere and converting them into limestone, which serves as a sustainable substitute for cement and sand. In addition to this innovative approach, Neustark also offers environmental services that involve recycling construction waste into fresh concrete. The company decomposes concrete waste into its original components—carbonate powder and gravel—allowing clients to recycle materials effectively while reducing the environmental impact associated with concrete production. Through these methods, Neustark aims to contribute positively to the construction industry and address climate change.
C12 Quantum Electronics
Venture Round in 2024
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.
Limula
Seed Round in 2024
Limula is a company that has developed an innovative platform technology designed to enhance the scalability of cell therapy production. By integrating a bioreactor and a centrifuge into a single device, Limula's solution enables healthcare providers to manufacture cell and gene therapies in a decentralized manner, bringing these treatments closer to patients. This platform, which includes hardware, software, and consumables, aims to make highly personalized and curative therapies more accessible. The automation of the production process not only increases safety and reproducibility but also allows for the large-scale manufacturing of cell therapy products, thereby addressing the critical need for improved access to gene-engineered therapies.
Retinai
Series A in 2024
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Bcomp
Series C in 2024
Bcomp Ltd. is a manufacturer based in Fribourg, Switzerland, specializing in natural fiber composites. Founded in 2003, the company produces innovative products such as ampliTex, a natural flax fiber available in various forms, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies, developed from years of research and patented innovations, allow for the creation of structural components that can effectively replace traditional materials like aluminum and carbon fiber. The company serves diverse industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure, focusing on enhancing efficiency in weight, rigidity, shock absorption, and damping. Bcomp collaborates closely with its customers to tailor solutions that meet specific needs while continuing to strengthen its research and development efforts through academic partnerships.
Artiria Medical
Series A in 2024
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.
Aktiia
Series A in 2024
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.
Groover
Series A in 2024
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.
Transmutex
Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
CellVoyant
Seed Round in 2024
CellVoyant Technologies Limited, founded in 2021, focuses on advancing biotechnology through an AI-first approach to stem cell-based therapies aimed at treating chronic diseases. The company employs AI-driven live cell imaging to predict and optimize stem cell differentiation, allowing for the scalable and precise manufacturing of various human cells and tissues. This innovative technology is rooted in research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. With a commitment to translating cutting-edge science into practical healthcare solutions, CellVoyant addresses significant challenges in medicine. The company, led by Founder and CEO Rafael Carazo, has garnered support from a network of investors experienced in AI and biotechnology. Currently generating $2.5 million in annual revenue, CellVoyant is positioned to make a substantial impact in the biotechnology sector through its transformative therapies.
rready
Series A in 2023
Rready is a provider of SaaS solutions focused on innovation management, aimed at fostering a culture of intrapreneurship within organizations. The company's platform engages employees by encouraging them to unleash their creativity and ambition, allowing them to take ownership of their ideas. Rready offers strategic support designed to drive cultural transformation and enhance business impact while improving employer branding. Its approach includes a gamified offline component and a scalable online platform, making the process of employee-driven innovation both enjoyable and educational. This dual-faceted system enables clients to effectively implement and scale intrapreneurship initiatives, ultimately leading to lasting cultural change within their organizations.
Fractory
Venture Round in 2023
Fractory Ltd is a company that operates an online platform for sheet metal fabrication, allowing users to upload CAD files and connect with partner service providers based on availability, location, and capabilities. Founded in 2019 and based in Manchester, United Kingdom, Fractory offers a range of services including laser cutting, plasma cutting, sheet metal fabrication, tube laser cutting, oxy cutting, waterjet cutting, metal bending, and surface treatment. The platform serves engineering companies in the United States, the United Kingdom, and Nordic Europe, facilitating on-demand manufacturing and enabling quick access to custom laser-cut parts, regardless of batch size. Fractory aims to streamline the manufacturing process and promote sustainability within the industry.
Memo Therapeutics
Series C in 2023
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.
Poppins
Venture Round in 2023
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Orakl Oncology
Seed Round in 2023
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered analysis. The company utilizes a distinct collection of patient tumor avatars that integrates both biological and clinical data to enhance cancer treatment options.
Nagi Bioscience
Series A in 2023
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.
MedTrace Pharma
Venture Round in 2023
MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.
Druid
Series B in 2023
Druid is an AI platform that specializes in the development and deployment of intelligent agents and applications designed to streamline business processes and enhance operational efficiency. Since its inception in 2018, Druid has focused on creating a seamless user experience by utilizing advanced Natural Language Processing technology, which allows its AI agents to understand and respond to user intent in a contextual manner. This technology facilitates rich interactions through omnichannel text and voice conversations, connecting employees, customers, and partners with enterprise systems. Druid has built a robust network of over 200 partners and serves more than 300 clients globally, aiming to provide each employee with an intelligent virtual assistant to improve productivity and technology return on investment.
Hylomorph
Series B in 2023
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.
Puraffinity
Series A in 2023
Puraffinity Ltd, founded in 2015 and based in London, specializes in innovative water treatment and purification solutions. The company, which was previously known as Customem Ltd before rebranding in July 2019, has developed a sustainable bio-based adsorbent material designed to effectively remove challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry, Puraffinity's technology allows for the selective capture of micro-pollutants, including pesticides, pharmaceuticals, and hazardous chemicals such as per- and polyfluoroalkyl substances. This capability enables clients to comply with stringent wastewater regulations while contributing to the protection of local ecosystems. Puraffinity is committed to addressing pressing water quality challenges through environmentally sustainable practices.
Verity
Series B in 2023
Verity Studios AG, founded in 2014 and based in Zurich, Switzerland, specializes in the development of indoor drone systems. The company is recognized as a leader in the indoor drone market, providing innovative solutions for both the live event and logistics industries. Verity offers end-to-end drone show production services that cater to bespoke events, theatrical productions, and entertainment shows, delivering captivating aerial performances for clients such as Cirque du Soleil and Madison Square Garden. Additionally, Verity has created a commercially successful inventory tracking solution using fully autonomous indoor drones, which is deployed in warehouses to enhance operational efficiency, reduce costs, and minimize errors. Its clientele includes prominent companies like Maersk and Samsung SDS. With a commitment to sustainability, Verity’s systems also aim to lower waste and carbon emissions.
ChargeX
Series B in 2023
ChargeX GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in electric vehicle charging solutions. The company designs and manufactures modular charging systems, known as Aqueduct, which cater to the daily energy demands of electric vehicles. These systems are particularly suited for installation in underground parking garages and parking lots, enhancing client competitiveness and customer satisfaction. In addition to its charging equipment, ChargeX also offers installation services, targeting residential, corporate, and infrastructural sectors to support the growing adoption of electric mobility.
Turn2X
Seed Round in 2023
Turn2x is focused on developing advanced technology for the production of renewable natural gas (RNG). The company specializes in constructing plants that convert renewable electricity from sources such as solar and wind into biogas. Additionally, Turn2x offers modular methanation reactors that can adapt to variable load changes, allowing industries to access a cleaner and more sustainable alternative to fossil natural gas. Through its innovative approach, Turn2x aims to contribute to the transition towards renewable energy solutions.
Axelera AI
Series A in 2023
Axelera AI focuses on providing specialized hardware and software platforms to enhance artificial intelligence tasks, particularly in edge computing. Its primary product, the Metis™ AI Platform, combines hardware and software to offer high-performance, energy-efficient AI inference solutions. The platform's innovative design has earned recognition as a CES® 2024 Innovation Awards Honoree. Established in 2021 after incubation by Bitfury and collaboration with imec, Axelera AI is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices in Belgium, Switzerland, and Italy. The company's team comprises experts in AI from leading firms and Fortune 500 companies, focusing on delivering sustainable edge applications through a custom dataflow architecture and multicore in-memory computing that minimizes power consumption.
ANYbotics
Series B in 2023
ANYbotics AG is a Swiss robotics company founded in 2016 and based in Zurich. The company specializes in developing autonomous legged robots designed for industrial applications, particularly in hazardous and complex environments. These robots feature advanced capabilities such as docking stations, robust waterproof designs, and various sensing technologies. They are equipped to perform tasks like asset monitoring, equipment health checks, and event detection, thereby enhancing productivity and safety for workers in sectors such as oil and gas, power, energy, mining, chemicals, transportation, and construction. With a team of over 100 employees, ANYbotics aims to support industrial facilities in their inspection needs, promoting more sustainable operations through intelligent robotic solutions.
EcoRobotix
Series B in 2023
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.
MultiOmic Health
Seed Round in 2023
MultiOmic Health is an AI-driven start-up specializing in drug discovery for metabolic syndrome-related diseases. The company collaborates with selected healthcare providers to collect and analyze de-identified patient data and bio-samples. Its MOHSAIC® platform integrates multi-omics analysis with computational systems biology modeling and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies, facilitating the creation of new therapeutic and diagnostic research and development programs. By focusing on precision medicine, MultiOmic Health aims to improve treatment options for patients suffering from metabolic syndrome.
Wingtra
Series B in 2023
Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.
Flyability
Series C in 2023
Flyability SA is a Swiss company founded in 2014 and based in Lausanne, specializing in the development and manufacturing of flying robots designed for industrial inspections in inaccessible and confined spaces. The company’s flagship product, Elios, is a collision-tolerant flying robot that allows for safe inspections in complex environments, such as within buildings and urban areas, reducing the need for human presence in hazardous situations. Flyability’s technology addresses critical issues in the rapidly growing drone industry, particularly concerning collision and injury risks. Its applications extend beyond industrial inspections to include search and rescue operations and security assessments, enabling professionals to gather vital data while ensuring safety. The company has received numerous accolades, including the Drones for Good Award, reflecting its commitment to innovation and societal impact.
Insolight
Venture Round in 2022
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of high-efficiency solar panels. The company has achieved significant advancements in solar technology, with modules reaching a record efficiency of 29 percent, which allows for a reduction in residential solar electricity costs to below 0.1 $/kWh. Insolight's innovative optical technology enhances efficiency while maintaining the simplicity of installation comparable to standard flat panels. The company's solar systems also incorporate an integrated tracking method to optimize energy capture, maximizing solar utility for agricultural applications. Insolight's business model focuses on developing intellectual property, overseeing wholesale distribution, and outsourcing manufacturing, ensuring a streamlined approach to delivering cost-effective solar solutions. The technology has been validated by reputable institutions, demonstrating its potential for widespread impact in both residential and agricultural sectors.
Beekeeper
Series C in 2022
Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.
Bob W
Series A in 2022
Bob W is a technology-driven hospitality provider that provides an alternative to hotels and short-stay apartments. Its exceptionally cool apartments cater to the 21st-century traveler who wants it all: the consistent quality of a hotel and the authentic flair and affordability of a short-stay rental. It combines both worlds in sustainably operated properties, which are currently available in Finland and Estonia but are expanding across Europe and beyond. The company was founded in 2018 and is headquartered in Helsinki, Finland.
Orbex Space
Series C in 2022
Founded in 2015, Orbex is a leading private launch services company in Europe, specializing in the small satellite industry. The company has developed a low carbon, high-performance micro-launch vehicle that supports the deployment of satellites into polar and sun-synchronous low Earth orbits from a modern launch site in central Europe. Orbex offers a flexible core launch service along with a range of supporting services aimed at simplifying the launch process for its customers. By operating from a European location, Orbex benefits from shorter supply lines, easier communication, and reduced operational costs. The company utilizes advanced materials and in-house technologies, including rocket engines and avionics, to ensure high reliability and flexible mission profiles, enabling timely launches for small, micro, and nano-satellites.
IRUBIS
Seed Round in 2022
IRUBIS GmbH, founded in 2017 and based in Munich, Germany, specializes in the development of mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company focuses on enhancing Fourier transform infrared (FTIR) spectroscopy to improve the analysis of protein-based drugs. Its innovative measurement systems enable real-time bioreactor monitoring, allowing for the online assessment of glucose and lactate levels without contamination risks. IRUBIS also produces a range of ATR crystals, including single-reflection and signal-enhanced varieties, aimed at advancing industry standards for bioprocess monitoring. The company’s technology supports both upstream and downstream bioprocessing, facilitating metabolite monitoring and the detection of target proteins and contaminants through machine-learning evaluation software.
Flyability
Series C in 2022
Flyability SA is a Swiss company founded in 2014 and based in Lausanne, specializing in the development and manufacturing of flying robots designed for industrial inspections in inaccessible and confined spaces. The company’s flagship product, Elios, is a collision-tolerant flying robot that allows for safe inspections in complex environments, such as within buildings and urban areas, reducing the need for human presence in hazardous situations. Flyability’s technology addresses critical issues in the rapidly growing drone industry, particularly concerning collision and injury risks. Its applications extend beyond industrial inspections to include search and rescue operations and security assessments, enabling professionals to gather vital data while ensuring safety. The company has received numerous accolades, including the Drones for Good Award, reflecting its commitment to innovation and societal impact.
tozero
Pre Seed Round in 2022
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, focuses on developing technology for recycling lithium-ion batteries. The company aims to create a scalable machine that recovers essential materials such as lithium, nickel, cobalt, graphite, and manganese in an environmentally sustainable manner. By facilitating the recovery of these critical materials, Tozero enables industries to reintegrate fresh raw materials back into the supply chain, thereby supporting broader decarbonization efforts.
marta
Seed Round in 2022
German Version below: marta offers a market place for families, people in need of care and European caregivers. We believe that, on the one hand everyone has the right to receive appropriate care and to age with dignity and on the other hand caregivers should be able to do their work under fair conditions. We are working on software solutions to connect caregivers with families across Europe and we support both parties during the entire process. In our own families we have seen that the current market is characterized by non-transparent services and does not deliver adequate quality. It is out mission to change that. That is why we at marta pursue the goal of making things better by applying our software solutions to fundamentally rebuilding the "24-hour" care market. Deutsche Version: marta bietet einen Marketplatz für Familien, pflegebedürftige Menschen und europäische Pflegekräfte. Aus unserer Sicht, hat zum einen jede/r das Recht darauf, angemessene Pflege zu erhalten und in Würde zu altern und zum anderen sollten Pflegekräfte unter fairen Bedingungen ihre Arbeit machen können. Wir arbeiten an dem Bau von Softwarelösungen, um Pflegekräfte mit Familien in ganz Europa zu verbinden und während der Betreuung zu begleiten. In unseren eigenen Familien haben wir gesehen, dass der derzeitige Markt von intransparenten Dienstleistungen geprägt ist und keine angemessene Qualität liefert. Deswegen verfolgen wir bei marta das Ziel, es durch unsere Softwarelösungen besser zu machen und den Markt der "24-Stunden" Pflege grundlegend neu aufzubauen.
Luminovo
Seed Round in 2022
Luminovo GmbH, founded in 2017 and based in Munich, Germany, specializes in providing artificial intelligence consulting and solutions tailored for the electronics industry. The company offers hybrid processing services designed to simplify and expedite the development and production processes of electronic products. Luminovo's innovative software facilitates data-driven insights for electronics designers, enhancing their ability to manage supply chains effectively. It empowers manufacturers by automating quoting and procurement processes, thereby fostering collaboration within the supply chain. This approach not only accelerates the path to market for electronic products but also promotes cost efficiency and sustainability in product development. Through its comprehensive offerings, Luminovo aims to reduce the time and resources required for bringing market-ready electronic products to fruition.
Piomic Medical
Series A in 2022
Piomic is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly in patients with hard-to-heal leg and foot ulcers. The company's flagship product, the COMS® One Therapy System, is a portable, hand-held device that uses optical and magnetic stimulation technologies to promote wound healing. Clinical studies demonstrate that this device is safe and effective, leading to accelerated wound closure, reduced pain, and improved quality of life for patients. Designed for ease of use, the device features a single-button operation and can be utilized in various settings, including stationary and ambulatory facilities, as well as in patients’ homes. By focusing on a therapy that provides significant benefits, Piomic seeks to improve the treatment outcomes for individuals suffering from chronic wounds and alleviate the cost burden on healthcare systems.
Oper
Series A in 2022
Oper is a reliable technology partner that enables lenders to leverage their mortgage offerings. The company helps credit providers to launch digital credit products in a matter of days. Credit providers can simply configure their process and start selling, by using Oper's out-of-the-box modules. The customers can integrate Fintech technologies into their process by choosing functionalities from Oper's Fintech partner app store.
Nuclera
Series B in 2022
Nuclera is a biotechnology company specializing in an automated protein prototyping system aimed at enhancing drug discovery processes. Its eProtein Discovery system enables researchers to rapidly produce and test high-quality, soluble, and active proteins, significantly accelerating protein projects. By integrating technology such as cell-free protein synthesis and digital microfluidics, Nuclera provides a high-throughput platform for automated protein access. This innovative approach allows scientists to obtain reliable proteins within a short timeframe, facilitating faster progress in their research and contributing to more efficient drug development efforts.
ORCA Computing
Series A in 2022
ORCA Computing Limited, founded in 2019 and located in Oxford, United Kingdom, specializes in the development of quantum computers utilizing photonic technology. The company is focused on creating scalable and flexible quantum computing systems powered by quantum memories, which enhance the storage and synchronization of quantum operations. By combining proprietary memory technology with standard telecom and optical fiber components, ORCA Computing offers a novel modular architecture that leverages the full potential of photonic computing. This innovative approach aims to unlock advanced applications across various industries, accelerate technological innovation, and significantly improve performance in quantum computing.
Invasight
Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Code Intelligence
Series A in 2022
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in security software aimed at helping developers identify and address vulnerabilities in their code. The company offers an automated application security testing platform that utilizes coverage-based fuzzing and symbolic code execution to generate attack inputs, thereby facilitating the detection of critical vulnerabilities and crashes. This solution significantly reduces the need for extensive expert knowledge by establishing a continuous testing infrastructure. Code Intelligence serves a diverse clientele, including notable organizations such as Bosch, Deutsche Börse Group, and Deutsche Telekom, ensuring that their software remains secure and reliable.
Therapixel
Series B in 2022
Therapixel SA is a French company specializing in the development of artificial intelligence-based medical image analytics software aimed at enhancing surgical procedures. Founded in 2013 and headquartered in Valbonne, France, Therapixel offers a range of products designed to assist healthcare professionals, including Radvise, an automatic image reading solution; Fluid, a touchless navigation system for surgical environments; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing outpatient imaging exams. The company's technology focuses on providing timely and relevant information to surgeons, ensuring they can access critical medical images before or during surgical operations. With additional locations in various countries, including Australia, China, and several nations across Europe and Latin America, Therapixel is committed to improving breast cancer detection and characterization through its innovative software solutions.
Helios.do
Seed Round in 2022
Leading sustainable banking alternative - 100% transparent and dedicated to limite climate change
SoterAI
Series A in 2022
Soter Analytics PTY LTD focuses on preventing musculoskeletal injuries in industrial workplaces through its innovative Soter Spine system, which combines wearable sensors and advanced analytics. The company provides devices that continuously monitor human movement, capturing health and locational data to identify at-risk movements and alert workers accordingly. By partnering with large industrial organizations, Soter integrates additional sensors, such as those for temperature and heart rate, to enhance safety and productivity. The company also offers an application that tracks long-term impacts and provides actionable recommendations for injury prevention. Founded in 2015 and based in Perth, Australia, Soter Analytics aims to set a new standard in workplace safety and ergonomics by leveraging AI-powered insights to foster a culture of safety and efficiency among workers.
Minut
Series B in 2022
Minut is a technology company focused on smart home solutions, specializing in the development of a device called Point. Founded in 2014, with headquarters in Malmö, Sweden and operations in Shenzhen, China, Minut's product is designed to enhance home security by monitoring environmental factors such as noise, temperature, and motion without using cameras. The device employs infrared motion detection and microphones to identify unusual activities and send alerts to users' smartphones. This approach allows homeowners to maintain security and privacy while fostering good neighborly relations, particularly benefiting short-term rental hosts. Minut's technology represents a significant advancement in IoT and smart home management, providing users with peace of mind regarding their properties.
holo|one
Series A in 2022
holo|one is a software company developing “sphere” – the award-winning, standardized Mixed Reality (MR) platform solution. It hails from Switzerland, with offices in Zurich, the Bay Area, and Chongqing, China.
Veesion
Series A in 2022
Veesion is a company based in Paris, France, that specializes in gesture recognition technology aimed at detecting shoplifting in the retail sector. Founded in 2018, Veesion has developed an intelligent video surveillance software that employs deep learning algorithms to analyze the footage from security cameras in real-time. This technology identifies gestures associated with theft and sends alerts to human operators, who can then confirm the incident and respond appropriately. Veesion's solution integrates seamlessly with existing surveillance systems, providing retailers and distributors with an innovative and ethical means of safeguarding their assets while optimizing the allocation of security personnel.
Oxford Medical Products
Venture Round in 2022
Oxford Medical Products is focused on developing an innovative gastro-retentive hydrogel technology aimed at addressing weight loss challenges. The company has created a self-expanding capsule that occupies space in the stomach, effectively reducing hunger and promoting significant weight loss. This technology is designed to expand rapidly upon ingestion, providing a lasting feeling of satiety. Over time, the capsule breaks down gradually and passes naturally through the digestive system. Comprising a team of scientists, medical professionals, and entrepreneurs, Oxford Medical Products is dedicated to providing a safe, effective, and affordable solution to one of the world's pressing health issues.
Sleepiz
Series A in 2022
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.
Zero Point Motion
Seed Round in 2022
Zero Point Motion specializes in the development of advanced inertial sensors that enhance precise positioning and navigation capabilities. By integrating cavity optomechanics with hybrid micro-electro-mechanical systems and photonic integrated circuit technology, the company delivers ultra-low noise performance for measuring acceleration and rotation. This innovative approach allows for high-quality motion tracking, making it suitable for various applications, including automotive systems, consumer electronics, and robotics. Through its focus on combining state-of-the-art optical properties with the mass production of existing sensor technologies, Zero Point Motion aims to provide reliable and efficient solutions for motion detection and navigation.
9T Labs
Series A in 2022
9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.
Memo Therapeutics
Series B in 2022
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.
Scrona
Series A in 2022
Scrona specializes in micro- and nanotechnology, focusing on innovative solutions for both consumer and industrial applications. The company has developed a three-dimensional nano drip printing technology aimed at facilitating fast and cost-effective production processes. Scrona's core competency lies in printhead development, collaborating with partners to offer comprehensive manufacturing equipment and next-generation products. This enables businesses to produce high-quality printed materials efficiently and at reduced costs, contributing to advancements in micro- and nanofabrication.
Nanoleq
Series A in 2021
Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.
Hylomorph
Series B in 2021
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.
Medimaps Group
Venture Round in 2021
Medimaps Group specializes in developing medical tools that enhance the assessment of bone microarchitecture, particularly for diagnosing and managing osteoporosis. The company's software utilizes artificial intelligence to analyze imaging data from various sources, including DXA, X-ray, and projected CT images, employing techniques such as the trabecular bone score. By providing detailed insights into bone texture, Medimaps Group aids physicians in selecting appropriate treatment options and monitoring patient outcomes. Additionally, the company is exploring future applications of its technology in the dental and orthopedic fields, further expanding its impact on patient care through improved assessment of bone health.
Beekeeper
Convertible Note in 2021
Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.
Kiutra
Venture Round in 2021
Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the manufacture of innovative refrigeration solutions, particularly magnetic cooling technology that provides cryogen-free cooling services. The company offers turn-key cryostats designed for research and industrial clients, facilitating low-temperature investigations of material samples and enhancing the development of quantum hardware and related electronics. Kiutra's cooling platforms achieve continuous sub-Kelvin temperatures without reliance on rare and costly helium-3, which simplifies the provision of cryogenic environments in a compact and cost-effective manner. This technology is crucial for various applications in quantum computing, quantum communications, and quantum sensing, enabling advancements in scalable quantum technologies.
PathoQuest
Series B in 2021
PathoQuest SAS is a biotechnology company that specializes in advanced metagenomics for pathogen detection, having originated as a spin-off from Institut Pasteur. The company utilizes proprietary next-generation sequencing (NGS) technology, which combines innovative sample preparation with a comprehensive database of pathogen genomic information. This approach allows clinicians and biopharmaceutical professionals to enhance the detection of infectious agents in various biological samples. PathoQuest's Viral Safety testing service, aimed at biopharmaceutical companies, represents its first commercial application and has rapidly generated revenue from major industry players. The company's cloud-based bioinformatics platform and automated analysis pipeline further facilitate improved pathogen detection, making its solutions valuable for both clinical and biopharmaceutical quality assurance.
Comgy
Venture Round in 2021
Comgy GmbH, founded in 2017 and based in Berlin, Germany, specializes in digital metering solutions for the housing and energy sectors. The company offers a range of products including a sub-metering solution that enables users to efficiently read meters, alongside sensors and smoke alarms. Comgy provides a Meter Gateway Management application, which acts as a control center for remote device configuration and data processing, as well as a Meter Installation Manager application for the digital registration of radiator measurements, supported by photographic documentation. Additionally, its Polyglot gateway facilitates encrypted communication between meters, sensors, and its customer platform. Comgy's technology enhances the measurement, visualization, and billing processes of heat, water, and electricity consumption in real estate, promoting transparency and facilitating energy savings.
Groover
Venture Round in 2021
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.
Aktiia
Series A in 2021
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.
Seervision
Funding Round in 2021
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.
Scewo
Series A in 2021
Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in designing and manufacturing innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that integrates both wheels and tracks, allowing for enhanced maneuverability over various terrains, including curbs, tram tracks, grass, and uneven surfaces. This self-balancing wheelchair features an active control system that maintains stability and levelness, enabling users to navigate obstacles with ease. Users can control the chair through a joystick or by shifting their body weight, providing a versatile solution to improve mobility and independence for those with disabilities.
EstateGuru
Series A in 2021
Estateguru is a leading Pan-European marketplace that facilitates property-backed loans for small and medium-sized enterprises (SMEs) while providing investment opportunities for a global investor base. The platform creates a digital and borderless ecosystem for real estate financing, connecting various service providers, SMEs, and investors in a single marketplace. By doing so, it offers a unique service that bypasses traditional banks and financial institutions, allowing for seamless cross-border transactions. Estateguru enhances returns for investors and expands borrowing options for businesses by managing short-term asset-backed property finance. With a team of 117 professionals from 21 nationalities, the company operates from locations including Berlin, Manchester, Helsinki, Yerevan, Tallinn, Riga, and Vilnius.
Fractory
Series A in 2021
Fractory Ltd is a company that operates an online platform for sheet metal fabrication, allowing users to upload CAD files and connect with partner service providers based on availability, location, and capabilities. Founded in 2019 and based in Manchester, United Kingdom, Fractory offers a range of services including laser cutting, plasma cutting, sheet metal fabrication, tube laser cutting, oxy cutting, waterjet cutting, metal bending, and surface treatment. The platform serves engineering companies in the United States, the United Kingdom, and Nordic Europe, facilitating on-demand manufacturing and enabling quick access to custom laser-cut parts, regardless of batch size. Fractory aims to streamline the manufacturing process and promote sustainability within the industry.
Sleepiz
Series A in 2021
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.
Humanoo
Series B in 2021
Humanoo is a digital health platform aimed at enhancing the physical and mental well-being of employees and insurance clients. The platform offers customized programs and innovative eHealth solutions in areas such as fitness, physiotherapy, yoga, mindfulness, and nutrition, helping users achieve their health goals. By providing comprehensive decentralized analysis, Humanoo enables companies and insurers to gain insights into the health of their employees or clients, facilitating measurable improvements. The team, comprised of 65 professionals from 15 countries, includes software developers, designers, marketing and sales specialists, as well as health and wellness experts such as sports scientists, nutritionists, yoga instructors, and physiotherapists. Humanoo's mission is to motivate individuals to maintain a healthy lifestyle and improve their overall productivity.
Salonkee
Series A in 2021
Salonkee S.A. is a Luxembourg-based company founded in 2016 that operates an online platform for booking salon appointments. This software development firm specializes in customer management and point-of-sale systems tailored for the hair and cosmetics sectors. Salonkee's platform offers features such as a digital calendar, automated appointment reminders via email and SMS, and tools for stock management. It enables users to easily search for services or salons and provides a streamlined process for editing and rescheduling appointments. By combining user-friendly design with automated features, Salonkee aims to enhance the overall experience of booking beauty services while supporting business development through comprehensive management statistics and marketing tools.
Otoqi
Series A in 2021
Otoqi specializes in developing an automotive management platform that streamlines the entire lifecycle of vehicles. The company's technology simplifies the logistics involved in moving, servicing, charging, repairing, and delivering a large number of vehicles. By facilitating instant ordering and providing real-time visibility and control during the buying process of new and used cars, Otoqi enhances operational efficiency. Additionally, it enables quick transfers of vehicles between various sites, agencies, and partners, while also offering comprehensive vehicle testing and after-sales services. This holistic approach allows mobility operators to access a full range of services tailored to their needs.
byrd
Series B in 2021
Byrd operates a fulfillment network designed to connect online merchants with an international warehouse system, facilitating advanced shipping options for retailers without the need to establish their own logistics infrastructure. The company's platform integrates seamlessly with popular e-commerce systems, such as Shopify, and collaborates with logistics partners across various countries to enhance retailers' reach. Byrd's technology-driven logistics solution features digital interfaces that link e-commerce platforms to its warehouse management system, utilized by partner warehouses globally. Additionally, Byrd offers real-time stock tracking and first-mile shipping services, including item pickup and packaging, which can be easily accessed via a mobile application. This comprehensive approach allows both private and business customers to efficiently manage their shipping needs.
Threatray
Seed Round in 2021
Threatray specializes in code-based threat intelligence, providing software that analyzes extensive malware repositories and feeds. By offering advanced analytics tools, the company enables enterprise security and incident response teams to gain a comprehensive understanding of cyber threats. Its platform focuses on analyzing data streams at the code level, identifying similarities with known threats, and swiftly detecting unknown malicious artifacts. This capability helps organizations protect against data leaks and secure their sensitive information effectively.
EcoRobotix
Venture Round in 2021
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.
Sympatient
Seed Round in 2021
Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, that specializes in virtual reality-based psychotherapy solutions for anxiety disorders. Founded in 2017, the company develops medical virtual reality applications aimed at enhancing mental health, particularly in anxiety and stress management. Its flagship products include Otemi, which helps users manage personal stress through various tasks and exercises, and Invirto, an application that provides therapeutic information and strategies for patients to independently treat their anxiety disorders at home. Sympatient also offers a CE-certified medical device for individuals diagnosed with anxiety disorders. By combining technology with traditional therapy methods, Sympatient aims to make mental health treatment more accessible and personalized for patients worldwide.
Stake
Seed Round in 2021
Stake is a digital platform that facilitates real estate investment, allowing individuals to invest in income-generating rental properties quickly and easily. The platform aims to modernize real estate investment by making it accessible to a broader audience. Stake achieves this by breaking down properties into smaller, investable shares, thereby enabling users to purchase stakes in residential properties. This approach not only democratizes real estate investment but also enhances transparency and profitability for investors. Through its innovative model, Stake provides a streamlined way for individuals to engage in the real estate market without the complexities traditionally associated with property investment.
Fineheart
Series B in 2021
Fineheart is a France-based medical device company that specializes in innovative technologies aimed at addressing cardiovascular diseases. The company is developing an implantable cardiac device that is wirelessly powered and fully implantable, designed to provide mechanical circulatory support. This novel device optimizes cardiac output while preserving the heart's natural contractility, thereby enabling patients with heart failure to restore normal cardiac function and improve their quality of life. Fineheart's focus on advanced medical solutions positions it as a key player in the evolving landscape of cardiovascular care.
EarlySight
Seed Round in 2021
EarlySight SA is a Swiss company, established in 2016 and based in Lausanne, that focuses on developing innovative medical devices for the early detection and treatment of eye diseases. The company has created an advanced eye fundus camera that enhances retinal imaging through precise illumination and real-time correction of ocular aberrations. This device utilizes cellular-level imaging technology to identify subtle structural changes in the retina, allowing for effective monitoring of treatment outcomes in a quick and non-invasive manner. By facilitating the visualization of cell morphology within the retina, EarlySight aims to improve the capabilities of eye specialists in diagnosing and managing ocular conditions.
Qnami
Series A in 2021
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
rready
Seed Round in 2021
Rready is a provider of SaaS solutions focused on innovation management, aimed at fostering a culture of intrapreneurship within organizations. The company's platform engages employees by encouraging them to unleash their creativity and ambition, allowing them to take ownership of their ideas. Rready offers strategic support designed to drive cultural transformation and enhance business impact while improving employer branding. Its approach includes a gamified offline component and a scalable online platform, making the process of employee-driven innovation both enjoyable and educational. This dual-faceted system enables clients to effectively implement and scale intrapreneurship initiatives, ultimately leading to lasting cultural change within their organizations.
Onward
Convertible Note in 2021
Onward is a company focused on developing mobile applications and online platforms that assist users in modifying compulsive behaviors related to technology and financial management. It combines data science and artificial intelligence to create personalized programs aimed at addressing issues such as excessive screen time, social media use, gambling, and spending habits. The company also offers financial wellness solutions, including direct savings plans and emergency lending options to help individuals build financial security. Established in 2015 and based in Los Angeles, California, Onward's mission centers around restoring a balance between technology and life by providing accessible and non-judgmental resources for behavior change. Through collaboration with clinical advisors from UCLA, Onward seeks to utilize advanced behavioral science to reach a broad audience globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.